. 2014 Feb 20;2014:301879. doi: 10.1155/2014/301879

Table 4.

Effects of CS extract treatment on the level of MMP-2, MMP-9, and TIMP-1 in the liver tissue at the end of 12 weeks.

Group	MMP-2 (ng/mL)	MMP-9 (ng/mL)	TIMP-1 (ng/mL)
Normal	2.57 ± 0.4^b	8.31 ± 1.2^b	1.91 ± 0.79^b
TAA	8.44 ± 1.06^a	46.57 ± 4.7^a	7.81 ± 0.85^a
CS100	2.44 ± 0.43^b	8.57 ± 8.11^b	1.83 ± 0.38^b
CS300	2.37 ± 0.65^b	8.8 ± 0.75^b	2.04 ± 0.67^b
CS100 + TAA	6.43 ± 0.569^a,b	22.76 ± 1.78^a,b	4.78 ± 1.01
CS300 + TAA	4.87 ± 0.77^a,b	15.51 ± 2.44^a,b	3.05 ± 0.63
SY + TAA	3.38 ± 0.525^b	13.84 ± 2.8^a,b	2.12 ± 0.48^b

The data were stated as mean ± S.E.M. Means with different superscripts are significantly different. ^a P < 0.05 versus normal control group and ^b P < 0.05 versus TAA control group. SY stands for Silymarin (standard hepatoprotective drug).